Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis
Introduction Brodalumab, an anti-IL17RA monoclonal antibody, is a treatment option for plaque psoriasis related to increased risk of suicidal ideation and behavior, including completed suicide.However, in the literature no causal relationship is reported, and the reported incidence of patients rece...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cambridge University Press
2022-06-01
|
| シリーズ: | European Psychiatry |
| 主題: | |
| オンライン･アクセス: | https://www.cambridge.org/core/product/identifier/S0924933822019575/type/journal_article |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|